Welcome to LookChem.com Sign In|Join Free
  • or
H(1+)*Gd(3+)*(CH3NC5H2OOCONH)2(CH2)6N2(COC6H2OOHCONHCH3)(4-)=HGd(CH3NC5H2O2CONH)2(CH2)6N2(COC6H2O2HCONHCH3) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

319430-97-2

Post Buying Request

319430-97-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

319430-97-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 319430-97-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,9,4,3 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 319430-97:
(8*3)+(7*1)+(6*9)+(5*4)+(4*3)+(3*0)+(2*9)+(1*7)=142
142 % 10 = 2
So 319430-97-2 is a valid CAS Registry Number.

319430-97-2Upstream product

319430-97-2Downstream Products

319430-97-2Relevant academic research and scientific papers

Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents

Cohen,Xu,Radkov,Raymond,Botta,Barge,Aime

, p. 5747 - 5756 (2000)

The tripodal ligand tris[(3-hydroxy-1-methyl-2-oxo-l,2-didehydropyridine-4-carboxamido)ethyl]amin e (TREN-Me-3,2-HOPO) forms a stable Gd3+ complex that is a promising candidate as a magnetic resonance imaging (MRI) contrast agent. However, its low water solubility prevents detailed magnetic characterization and practical applicability. Presented here are a series of novel mixed ligand systems that are based on the TREN-Me-3,2-HOPO platform. These new ligands possess two hydroxypyridinone (HOPO) chelators and one other chelator, the latter of which can be easily functionalized. The ligands described use salicylamide, 2-hydroxyisophthalamide, 2,3-dihydroxyterephthalamide, and bis(acetate) as the derivatizable chelators. The solution thermodynamics and relaxivity properties of these new systems are presented. Three of the four complexes (salicylamide-, 2-hydroxyisophthalamide-, and 2,3-dihydroxyterephthalamide-based ligands) possess sufficient thermodynamic stability for in vivo applications. The relaxivities of the three corresponding Gd3+ complexes range from 7.2 to 8.8 mM-1 s-1 at 20 MHz, 25 °C, and pH 8.5, significantly higher than the values for the clinically employed polyaminocarboxylate complexes (3.5-4.8 mM-1 s-1). The high relaxivities of these complexes are consistent with their faster rates of water exchange (700), and greater numbers of inner-sphere coordinated water molecules (q = 2) relative to those of polyaminocarboxylate complexes. A mechanism for the rapid rates of water exchange is proposed involving a low energy barrier between the 8- and 9-coordinate geometries for lanthanide complexes of HOPO-based ligands. The pathway is supported by the crystal structure of La[TREN-Me-3,2-HOPO] (triclinic P1: Z = 4, a = 15.6963(2) A, b = 16.9978(1) A, c = 17.1578(2) A, α = 61.981(1)°, β = 75.680(1)°, γ = 71.600(1)°), which shows both 8- and 9-coordinate metal centers in the asymmetric unit, demonstrating that these structures are very close in energy. These properties make heteropodate Gd3+ complexes promising candidates for use in macromolecular contrast media, particularly at higher magnetic field strengths.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 319430-97-2